157 related articles for article (PubMed ID: 37191984)
1. Pulmonary fibrosis in COVID-19: mechanisms, consequences and targets.
O'Reilly S
QJM; 2023 Oct; 116(9):750-754. PubMed ID: 37191984
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients.
Giacomelli C; Piccarducci R; Marchetti L; Romei C; Martini C
Biochem Pharmacol; 2021 Nov; 193():114812. PubMed ID: 34687672
[TBL] [Abstract][Full Text] [Related]
3. Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients.
Chen Y; Qin Y; Fu Y; Gao Z; Deng Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555339
[TBL] [Abstract][Full Text] [Related]
4. Healing after COVID-19: are survivors at risk for pulmonary fibrosis?
McDonald LT
Am J Physiol Lung Cell Mol Physiol; 2021 Feb; 320(2):L257-L265. PubMed ID: 33355522
[TBL] [Abstract][Full Text] [Related]
5. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
Michalski JE; Kurche JS; Schwartz DA
Transl Res; 2022 Mar; 241():13-24. PubMed ID: 34547499
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary fibrosis in patients with COVID-19: A review].
Chuchalin AG
Ter Arkh; 2022 Dec; 94(11):1333-1339. PubMed ID: 37167174
[TBL] [Abstract][Full Text] [Related]
7. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.
Venkataraman T; Coleman CM; Frieman MB
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404843
[TBL] [Abstract][Full Text] [Related]
8. Potential mechanisms for lung fibrosis associated with COVID-19 infection.
Parimon T; Espindola M; Marchevsky A; Rampolla R; Chen P; Hogaboam CM
QJM; 2023 Jul; 116(7):487-492. PubMed ID: 36018274
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.
John AE; Joseph C; Jenkins G; Tatler AL
Immunol Rev; 2021 Jul; 302(1):228-240. PubMed ID: 34028807
[TBL] [Abstract][Full Text] [Related]
10. Recent Findings on Cell-Based Therapies for COVID19-Related Pulmonary Fibrosis.
Chuang HM; Ho LI; Harn HJ; Liu CA
Cell Transplant; 2021; 30():963689721996217. PubMed ID: 33845643
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19.
Morganstein T; Haidar Z; Trivlidis J; Azuelos I; Huang MJ; Eidelman DH; Baglole CJ
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884756
[TBL] [Abstract][Full Text] [Related]
12. Lung recovery with prolonged ECMO following fibrotic COVID-19 acute respiratory distress syndrome.
Kazi AW; Summer R; Sundaram B; George G
Am J Med Sci; 2023 Mar; 365(3):307-312. PubMed ID: 36535539
[TBL] [Abstract][Full Text] [Related]
13. Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target.
Ntatsoulis K; Karampitsakos T; Tsitoura E; Stylianaki EA; Matralis AN; Tzouvelekis A; Antoniou K; Aidinis V
Front Immunol; 2021; 12():687397. PubMed ID: 34671341
[TBL] [Abstract][Full Text] [Related]
14. [Research advances in the mechanism of pulmonary fibrosis induced by coronavirus disease 2019 and the corresponding therapeutic measures].
Wang J; Wang BJ; Yang JC; Wang MY; Chen C; Luo GX; He WF
Zhonghua Shao Shang Za Zhi; 2020 Aug; 36(8):691-697. PubMed ID: 32174095
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals.
Al-Kuraishy HM; Batiha GE; Faidah H; Al-Gareeb AI; Saad HM; Simal-Gandara J
Inflammopharmacology; 2022 Dec; 30(6):2017-2026. PubMed ID: 36044102
[TBL] [Abstract][Full Text] [Related]
16. Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9.
Oatis D; Simon-Repolski E; Balta C; Mihu A; Pieretti G; Alfano R; Peluso L; Trotta MC; D'Amico M; Hermenean A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897786
[TBL] [Abstract][Full Text] [Related]
17. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis.
Venkataraman T; Frieman MB
Antiviral Res; 2017 Jul; 143():142-150. PubMed ID: 28390872
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients.
Krygier A; Szmajda-Krygier D; Świechowski R; Pietrzak J; Wosiak A; Wodziński D; Balcerczak E
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551272
[TBL] [Abstract][Full Text] [Related]
19. Virus infection induced pulmonary fibrosis.
Huang WJ; Tang XX
J Transl Med; 2021 Dec; 19(1):496. PubMed ID: 34876129
[TBL] [Abstract][Full Text] [Related]
20. Increasing incidence of lung transplantation in patients with post-COVID-19 pulmonary fibrosis.
Khajotia R
Pan Afr Med J; 2021; 40():169. PubMed ID: 34970411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
